Qlife receives 3,45 MUSD funding from FIND to develop a respiratory assay in global fight against COVID-19 and influenza
COVID-19 represents one of the toughest global health challenges, as does recurrent influenza outbreaks. FIND, in the context of the Access to COVID-19 Tools (ACT) Accelerator diagnostics pillar, aims to accelerate development and delivery of affordable point-of-care, molecular diagnostics in low and middle-income countries. With this funding, Qlife joins forces with FIND to bring its diagnostic tests to people worldwide to defeat COVID-19 and other respiratory viruses.Qlife has signed an agreement with FIND, the global alliance for diagnostics, for an funding of 3,45 MUSD for a 12-month